Citations

Showing 10 of 108083 citations.

A Reconfigurable Multiplanar In Vitro Simulator for Real-Time Absolute Motion With External and Musculotendon Forces
Green, Joshua T. , Hale, Rena F. , Hausselle, Jérôme, Gonzalez, Roger V.

Mayo Clinic

Journal of Biomechanical Engineering | September 7, 2017 | Volume: 139 | Issue: 12 | Pages: No page available

10.1115/1.4037853 | PMID 28877307 Get It

Advancements in computational musculoskeletal biomechanics are constrained by a lack of experimental measurement under real-time physiological loading conditions. This paper presents the design, configuration, capabilities, accuracy, and repeatability of The University of Texas at El Paso Joint Load Simulator (UTJLS) by testing four cadaver knee specimens with 47 real-time tests including heel and toe squat maneuvers with and without musculotendon forces. The UTJLS is a musculoskeletal simulator consisting of two robotic manipulators and eight musculotendon actuators. Sensors include eight tension load cells, two force/torque systems, nine absolute encoders, and eight incremental encoders. A custom control system determines command output for position, force, and hybrid control and collects data at 2000 Hz. Controller configuration performed forward-dynamic control for all knee degrees-of-freedom (DOFs) except knee flexion. Actuator placement and specimen potting techniques uniquely replicate muscle paths. Accuracy and repeatability standard deviations across specimen during squat simulations were equal or less than 8 N and 5 N for musculotendon actuators, 30 N and 13 N for ground reaction forces (GRFs), and 4.4 N·m and 1.9 N·m for ground reaction moments. The UTJLS is the first of its design type. Controller flexibility and physical design support axis constraints to match traditional testing rigs, absolute motion, and synchronous real-time simulation of multiplanar kinematics, GRFs, and musculotendon forces. System DOFs, range of motion, and speed support future testing of faster maneuvers, various joints, and kinetic chains of two connected joints.
The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma
Moigne, Ronan Le , Aftab, Blake T. , Djakovic, Stevan, Dhimolea, Eugen , Murnane, Megan, King, Emily M. , Soriano, Ferdie, Menon, Mary-Kamala, Wu, Zhi , Lee, Grace J. , Lam, Christine , Rice, Julie , Wang, Jinhai , Chesi, Marta , Bergsagel, P. Leif , Kraus, Marianne , Driessen, Christoph , Soly, Szerenke Kiss Von, Yakes, F. Michael, Wustrow, David J., Shawver, Laura K. , Zhou, Han-Jie , Wolf, Jeffrey L. , Mitsiades, Constantine S. , Rolfe, Mark , Bergsagel, P. Leif , Junior, Eduardo Alves do Valle , Wong, Stephen T.C. , Yao, Bing , Wiita, Arun P. , Martin, Thomas G. , Anderson, Daniel J.

Mayo Clinic

Molecular Cancer Therapeutics | September 6, 2017 | Volume: 16 | Issue: 11 | Pages: 2375-2386

10.1158/1535-7163.mct-17-0233 | PMID 28878026 Get It

Abstract Inhibition of the AAA ATPase, p97, was recently shown to be a novel method for targeting the ubiquitin proteasome system, and CB-5083, a first-in-class inhibitor of p97, has demonstrated broad antitumor activity in a range of both hematologic and solid tumor models. Here, we show that CB-5083 has robust activity against multiple myeloma cell lines and a number of in vivo multiple myeloma models. Treatment with CB-5083 is associated with accumulation of ubiquitinated proteins, induction of the unfolded protein response, and apoptosis. CB-5083 decreases viability in multiple myeloma cell lines and patient-derived multiple myeloma cells, including those with background proteasome inhibitor (PI) resistance. CB-5083 has a unique mechanism of action that combines well with PIs, which is likely owing to the p97-dependent retro-translocation of the transcription factor, Nrf1, which transcribes proteasome subunit genes following exposure to a PI. In vivo studies using clinically relevant multiple myeloma models demonstrate that single-agent CB-5083 inhibits tumor growth and combines well with multiple myeloma standard-of-care agents. Our preclinical data demonstrate the efficacy of CB-5083 in several multiple myeloma disease models and provide the rationale for clinical evaluation as monotherapy and in combination in multiple myeloma. Mol Cancer Ther; 16(11); 2375–86. ©2017 AACR.
Spirohexene-Tetrazine Ligation Enables Bioorthogonal Labeling of Class B G Protein-Coupled Receptors in Live Cells
Ramil, Carlo P. , Dong, Maoqing , An, Peng , Lewandowski, Tracey M., Lin, Qing , Miller, Laurence J. , Lin, Qing , Yu, Zhipeng

Mayo Clinic

Journal of the American Chemical Society | September 6, 2017 | Volume: 139 | Issue: 38 | Pages: 13376-13386

10.1021/jacs.7b05674 | PMID 28876923 Get It

Definitions and statistical properties of master protocols for personalized medicine in oncology
Renfro, Lindsay A. , Mandrekar, Sumithra J.

Mayo Clinic

Journal of Biopharmaceutical Statistics | September 6, 2017 | Volume: 28 | Issue: 2 | Pages: 217-228

10.1080/10543406.2017.1372778 | PMID 28877008 Get It

Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis
Greuter, Thomas , Shah, Vijay H. , Malhi, Harmeet , Gores, Gregory J.

Mayo Clinic

JCI Insight | September 6, 2017 | Volume: 2 | Issue: 17 | Pages: No page available

10.1172/jci.insight.95354 | PMID 28878132 Get It

Alcoholic steatohepatitis (ASH) and nonalcoholic steatohepatitis (NASH) are among the most frequent causes of chronic liver disease in the United States. Although the two entities are triggered by different etiologies — chronic alcohol consumption (ASH) and obesity-associated lipotoxicity (NASH) — they share overlapping histological and clinical features owing to common pathogenic mechanisms. These pathogenic processes include altered hepatocyte lipid metabolism, organelle dysfunction (i.e., ER stress), hepatocyte apoptosis, innate immune system activation, and hepatic stellate cell activation. Nonetheless, there are several disease-specific molecular signaling pathways, such as differential pathway activation downstream of TLR4 (MyD88-dependence in NASH versus MyD88-independence in ASH), inflammasome activation and IL-1β signaling in ASH, insulin resistance and lipotoxicity in NASH, and dysregulation of different microRNAs, which clearly highlight that ASH and NASH are two distinct biological entities. Both pathogenic similarities and differences have therapeutic implications. In this Review, we discuss these pathogenic mechanisms and their therapeutic implications for each disease, focusing on both shared and distinct targets.
Cadherin complexes recruit mRNAs and RISC to regulate epithelial cell signaling
Kourtidis, Antonis , Necela, Brian M. , Lin, Wan-Hsin, Lu, Ruifeng , Feathers, Ryan W. , Asmann, Yan W. , Thompson, E. Aubrey , Anastasiadis, Panos Z. , Necela, Brian , Lin, Wan‐Hsin

Mayo Clinic

Journal of Cell Biology | September 6, 2017 | Volume: 216 | Issue: 10 | Pages: 3073-3085

10.1083/jcb.201612125 | PMID 28877994 Get It

Cumulative evidence demonstrates that most RNAs exhibit specific subcellular distribution. However, the mechanisms regulating this phenomenon and its functional consequences are still under investigation. Here, we reveal that cadherin complexes at the apical zonula adherens (ZA) of epithelial adherens junctions recruit the core components of the RNA-induced silencing complex (RISC) Ago2, GW182, and PABPC1, as well as a set of 522 messenger RNAs (mRNAs) and 28 mature microRNAs (miRNAs or miRs), via PLEKHA7. Top canonical pathways represented by these mRNAs include Wnt/β-catenin, TGF-β, and stem cell signaling. We specifically demonstrate the presence and silencing of MYC, JUN, and SOX2 mRNAs by miR-24 and miR-200c at the ZA. PLEKHA7 knockdown dissociates RISC from the ZA, decreases loading of the ZA-associated mRNAs and miRNAs to Ago2, and results in a corresponding increase of MYC, JUN, and SOX2 protein expression. The present work reveals a mechanism that directly links junction integrity to the silencing of a set of mRNAs that critically affect epithelial homeostasis.
The Ideal Hospital Discharge Summary: A Survey of U.S. Physicians
Sorita, Atsushi , Robelia, Paul M., Kattel, Sharma , Keller, A. Scott, Almasri, Jehad , Newman, James S. , Kashiwagi, Deanne T. , Kattel, Sharma B, Murad, Mohammad Hassan, McCoy, Christopher P. , Murad, M. Hassan

Mayo Clinic

Journal of Patient Safety | September 6, 2017 | Volume: 17 | Issue: 7 | Pages: e637-e644

10.1097/pts.0000000000000421 | PMID 28885382 Get It

Background Hospital discharge summaries enable communication between inpatient and outpatient physicians. Despite existing guidelines for discharge summaries, they are frequently suboptimal. Objective The aim of this study was to assess physicians’ perspectives about discharge summaries and the differences between summaries’ authors (hospitalists) and readers (primary care physicians [PCPs]). Methods A national survey of 1600 U.S. physicians was undertaken. Primary measures included physicians’ preferences in discharge summary standardization, content, format, and audience. Results A total of 815 physicians responded (response rate = 51%). Eighty-nine percent agreed that discharge summaries “should have a standardized format.” Most agreed that summaries should “document everything that was done, found, and recommended in the hospital” (64%) yet “only include details that are highly pertinent to the hospitalization” (66%). Although 74% perceived patients as an important audience of discharge summaries, only 43% agreed that summaries “should be written in language that patients…can easily understand,” and 68% agreed that it “should be written solely for provider-to-provider communication.” Compared with hospitalists, PCPs preferred comprehensive summaries (68% versus 59%, P = 0.002). More PCPs agreed that separate summaries should be created for patients and for provider-to-provider communication than hospitalists (60% versus 47%, P < 0.001). Compared with PCPs, more hospitalists believe that “hospitalists are too busy to prepare a high-quality discharge summary” (44% versus 23%, P < 0.001) and “PCPs have insufficient time to read an entire discharge summary” (60% versus 38%, P < 0.001). Conclusions Physicians believe that discharge summaries should have a standardized format but do not agree on how comprehensive or in what format they should be. Efforts are necessary to build consensus toward the ideal discharge summary.
HPV-related Multiphenotypic Sinonasal Carcinoma
Andreasen, Simon , Hang, Jen‐Fan , Bullock, Martin , Chen, Tiffany , García, Joaquín J. , Gnepp, Douglas R., Gomez‐Fernandez, Carmen , Ihrler, Stephan , Kuo, Ying‐Ju , Lewis, James S. , Magliocca, Kelly R. , Sandison, Ann , Uro‐Coste, Emmanuelle , Stelow, Edward B. , Kiss, Katalin , Westra, William H. , Bishop, Justin A. , Franchi, Alessandro , Pambuccian, Stefan E.

Mayo Clinic

American Journal of Surgical Pathology | September 6, 2017 | Volume: 41 | Issue: 12 | Pages: 1690-1701

10.1097/pas.0000000000000944 | PMID 28877065 Get It

Human papillomavirus (HPV)–related multiphenotypic sinonasal carcinoma (HMSC), originally known as HPV-related carcinoma with adenoid cystic carcinoma-like features, is a peculiar neoplasm that is restricted to the sinonasal tract, exhibits features of both a surface-derived and salivary gland carcinoma (particularly adenoid cystic carcinoma), and is associated with high-risk HPV. Given the limited number of published cases, the full clinicopathologic spectrum of this neoplasm is unclear. Here, we present an updated experience of 49 cases. All cases of HMSC were obtained from the authors’ files. Immunohistochemistry for p16, c-kit, and myoepithelial cell markers (S100, actin, calponin, p63, and/or p40) was performed along with RNA in situ hybridization for HPV (type 33-specific as well as a high-risk cocktail). Fluorescence in situ hybridization studies for fusions ofMYB,NFIB, andMYBL1was performed on a subset of cases. Clinical follow-up was obtained from medical records. A total of 49 cases of HMSC were collected. Twenty-eight (57%) were from women and 18 (43%) from men, ranging in age from 28 to 90 years (mean, 54 y). Of 40 cases with detailed staging information, 43% of HMSCs presented with a high T-stage (T3 or T4). Histologically, most grew predominantly as solid nests of basaloid cells exhibiting high mitotic rates and frequent necrosis, with histologic and immunohistochemical evidence of myoepithelial differentiation. Most cases also demonstrated foci of cribriform and/or tubular growth, along with an inconspicuous population of ducts. Thirty-four (69%) cases demonstrated an unusual pattern of surface involvement where markedly atypical squamous cells colonized tracts of the sinonasal mucosa. Less consistent histologic features included squamous differentiation within the invasive tumor (n=6), sarcomatoid transformation (n=5) including overt chondroid differentiation (n=3), and prominent epithelial-myoepithelial carcinoma-like growth (n=3). All cases were positive for p16 by immunostaining and HPV by RNA in situ hybridization. Thirty-three (67%) were positive for HPV 33. No cases tested forMYB,MYBL1, orNFIBgene fusions were positive. In the 38 cases with follow-up data, (mean follow-up, 42 mo) 14 recurred locally and 2 metastasized (lung, finger). There were no regional lymph node metastases, and no tumor-related deaths. HMSC is a distinct sinonasal neoplasm characterized by myoepithelial differentiation, frequent surface epithelial involvement, and the presence of high-risk HPV (especially type 33). Although it classically exhibits a cribriforming pattern that closely resembles adenoid cystic carcinoma, our expanded series highlights a histologic spectrum that is much broader than previously recognized, warranting a change in terminology. HMSC usually presents as a large and destructive sinonasal mass with high-grade histologic features, but it paradoxically behaves in a relatively indolent manner, underscoring the importance of distinguishing HMSC from true adenoid cystic carcinoma, squamous cell carcinoma, and other histologic mimickers.
A 3-Dimensional Printed Ultrasound Probe Visuospatial Trainer
McKenna, Ryan , Dove, Jesse, Ratzlaff, Robert A. , Díaz‐Gómez, José L. , Cox, Daniel , Simon, Leslie V. , Díaz-Gómez, José L

Mayo Clinic

Ultrasound Quarterly | September 6, 2017 | Volume: 34 | Issue: 2 | Pages: 103-105

10.1097/ruq.0000000000000318 | PMID 28877098 Get It

Abstract Training adult learners to use ultrasound in clinical practice relies on the ability of the learner to apply visuospatial concepts to the anatomy of the human body. We describe a visuospatial trainer that replicates the housing of an ultrasound transducer, through which a linear laser projects light in the same plane and orientation as the ultrasonic sound waves. We use this trainer in combination with a porcine heart dissection laboratory to teach bedside cardiac ultrasound and transthoracic echocardiography (TTE). Off-the-shelf components, including an on/off switch, a laser, and 2 ampere batteries are connected in series and placed inside the 3-dimensional (3D)–printed housing. The trainer's laser emission projects a red line that visually represents the ultrasound's field. Learners project the laser against a porcine or human heart in the orientation of the TTE window they wish to obtain and then dissect the heart in that plane, allowing for visualization of how grayscale images are obtained from 3D structures. Previous research has demonstrated that visuospatial aptitude is correlated with ultrasound procedural performance. We present this trainer and educational method as a specific training intervention that could enhance the visuospatial ability of the ultrasound learner. This visuospatial trainer and educational method present a novel process for enhancing learner understanding of 2-dimensional ultrasound images as they relate to 3D structures. Having a clear understanding of how images are generated in cross section may translate into more proficient adaptation of cardiac ultrasound and TTE.
Academic Medicine and Medical Professionalism: A Legacy and a Portal Into an Evolving Field of Educational Scholarship
Hafferty, Frederic W.

Mayo Clinic

Academic Medicine | September 6, 2017 | Volume: 93 | Issue: 4 | Pages: 532-536

10.1097/acm.0000000000001899 | PMID 28877035 Get It

In this Invited Commentary, the author examines two curated Academic Medicine volumes showcasing foundational research and key writings on professionalism in medicine and medical education, collectively spanning from 1994 to 2016. The author reviews the beginnings of the medical professionalism movement and examines how the trends and themes reflected in the first volume—specifically the work to define, assess, and institutionalize professionalism—capture key elements in this movement. He then examines how the trends and themes in the second volume align with and build on those from the first, noting two themes that extend across a number of second volume articles: a unit-of-analysis issue and the challenge of context. The author identifies several topics that have yet to be adequately mined and calls attention to two bridge-spanning articles in the second volume that, respectively, take us into the future (around the topic of identify formation) and back to the past (on the hidden curriculum). Finally, the author reflects on “directions home” in medicine’s noble search for its moral core and collective identity.